Dysferlin is a novel regulator of COMP-positive matrifibrocytes in heart failure
Ievgeniia Kocherova, Muriel Giger, Andrea Laimbacher, Lukas Minder, Daria Nurzyńska, Franca Di Meglio, Gino Andrea Bonazza, Elena Pachera, Filip Rolski, Michał Ma̧czewski, Przemysław Leszek, Michele Visentin, Oliver Distler, Przemysław Błyszczuk, Gabriela Kania
This study identifies dysferlin as an antifibrotic regulator that limits fibroblast differentiation and myocardial fibrosis in heart failure.
bioRxiv · Aug 21, 2026 · PreprintCell Biology